Send us Feedback

Biogen Idec (BIIB)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

BIIB » Topics » Issuer Purchases of Equity Securities

This excerpt taken from the BIIB 10-Q filed Apr 17, 2009.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		    Number of Shares
 		 
                Shares Purchased
 		    That May Yet Be
 		 
    Total Number of
 		    Average Price Paid
 		    as Part of Publicly
 		    Purchased Under Our
 		 
    Shares Purchased
 		    per Share
 		    Announced Program
 		    Program
 		 
Period
  (#)     ($)     (#)(a)     (#)(a)  
 
Jan-09
    1,222,500     $ 47.12       14,000,000       6,000,000  
                                 
Total(a)
    1,222,500     $ 47.12       14,000,000       6,000,000  
                                 
 
 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date. We publicly announced the repurchase program in our press release dated October 31, 2006, which was furnished to the SEC as Exhibit 99.1 of our Current Report on Form 8-K filed on October 31, 2006.
 
Item 6.   Exhibits
 
The exhibits listed on the Exhibit Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q.


61

Table of Contents

This excerpt taken from the BIIB 10-K filed Feb 6, 2009.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		       
                Shares Purchased as
 		    Number of Shares
 		 
    Total Number of
 		    Average Price Paid
 		    Part of Publicly
 		    That May Yet Be
 		 
    Shares Purchased
 		    Per Share
 		    Announced Program
 		    Purchased Under Our
 		 
Period
  (#)     ($)     (#)(a)     Program (#)  
 
March 2008
    4,028,196     $ 59.61       4,028,196       15,971,804  
April 2008
    4,971,804     $ 64.27       4,971,804       11,000,000  
December 2008
    3,777,500     $ 47.41       3,777,500       7,222,500  
                                 
Total(a)(b)
    12,777,500     $ 57.82       12,777,500       7,222,500  
                                 


35

Table of Contents

 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date. We publicly announced the repurchase program in our press release dated October 31, 2006, which was furnished to the SEC as Exhibit 99.1 to our current report on Form 8-K filed on October 31, 2006.
 
(b) After December 31, 2008, we repurchased approximately 1.2 million additional shares at a total cost of $57.6 million.
 
This excerpt taken from the BIIB 10-Q filed Apr 23, 2008.
Issuer Purchases of Equity Securities
 
                                 
            Total Number of
 		   
            Shares Purchased as
 		  Number of Shares
    Total Number of
 		  Average Price
 		  Part of Publicly
 		  that may yet be
    Shares Purchased
 		  Paid per Share
 		  Announced Program
 		  Purchased Under Our
Period
  (#)   ($)   (#)(a)   Program (#)(a)
 
March 2008
    4,028,196     $ 59.61       4,028,196       15,971,804  
                                 
Total
    4,028,196     $ 59.61       4,028,196       15,971,804  
                                 
 
 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date. We publicly announced the repurchase program in our press release dated October 31, 2006, which was furnished to the SEC as Exhibit 99.1 of our Current Report on Form 8-K filed on October 31, 2006.
 
Item 6.   Exhibits
 
         
  4 .1(1)   Indenture dated as of February 26, 2008 between us and the Bank of New York Trust Company, N.A., as Trustee
  4 .2(2)   First Supplemental Indenture dated as of March 4, 2008 between us and the Bank of New York Trust Company, N.A., as Trustee
  31 .1   Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31 .2   Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32 .1   Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  (1)     Incorporated by reference from an exhibit filed with our Registration Statement on Form S-3, File No. 333-149379, filed on February 26, 2008.
  (2)     Incorporated by reference from an exhibit filed with our current report on Form 8-K filed on March 4, 2008.


44

Table of Contents

This excerpt taken from the BIIB 10-K filed Feb 14, 2008.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		       
                Shares Purchased as
 		    Number of Shares
 		 
    Total Number of
 		    Average Price Paid
 		    Part of Publicly
 		    that may yet be
 		 
    Shares Purchased
 		    per Share
 		    Announced Program
 		    Purchased under Our
 		 
Period
  (#)     ($)     (#)(a)(c)     Program (#)  
 
March 2007
    8,041 (b)   $ 44.99       —       20,000,000  
April 2007
    747 (b)   $ 44.91       —       20,000,000  
July 2007
    56,424,155 (c)   $ 53.00       —       20,000,000  
      1,231 (b)   $ 54.76       —       20,000,000  
September 2007
    12,897 (b)   $ 66.53       —       20,000,000  
                                 
Total(c)
    56,447,071     $ 53.00       —       20,000,000  


44

Table of Contents

 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. No purchases have been made under this authorization. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date. We publicly announced the repurchase program in our press release dated October 31, 2006, which was furnished to the SEC as Exhibit 99.1 of our current report on Form 8-K filed on October 31, 2006.
 
(b) All of these shares are shares that were used by certain employees to pay the exercise price of their stock options in lieu of paying cash or utilizing our cashless option exercise program.
 
(c) As more fully described in Note 20, Tender Offer, in the accompanying notes to consolidated financial statements in Part IV of this report on Form 10-K, in July 2007 we consummated a tender offer announced on May 29, 2007 whereby we repurchased 56,424,155 shares of our common stock at a price of $53.00 per share.


45

Table of Contents

Item 6.   Selected Consolidated Financial Data
 
The following financial data should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this report on Form 10-K, beginning on page F-1.
 
BIOGEN IDEC INC. AND SUBSIDIARIES
 
This excerpt taken from the BIIB 10-Q filed Oct 23, 2007.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		       
                Shares Purchased as
 		    Number of Shares
 		 
    Total Number of
 		    Average Price
 		    Part of Publicly
 		    that may yet be
 		 
    Shares Purchased
 		    Paid per Share
 		    Announced Program
 		    Purchased Under Our
 		 
Period
  (#)     ($)     (#)(a)     Program (#)(a)  
 
Jul-07
    56,424,155 (c)   $ 53.00              —       20,000,000  
      1,231 (b)     54.76       —       20,000,000  
Sep-07
    12,897 (b)     66.53       —       20,000,000  
                                 
Total
    56,438,283     $ 53.00       —       20,000,000  
 
 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date. No purchases have been made under this plan. We publicly announced the repurchase program in our press release dated October 31, 2006, which was furnished to the SEC as Exhibit 99.1 of our Current Report on Form 8-K filed on October 31, 2006.
 
(b) All of these shares are shares that were used by certain employees to pay the exercise price of their stock options in lieu of paying cash or utilizing our cashless option exercise program.
 
(c) As more fully described in Note 15, “Tender Offer,” in the accompanying notes to consolidated financial statements in Part I of this report on Form 10-Q, in July 2007 we consummated a tender offer announced on May 29, 2007 whereby we repurchased 56,424,155 shares of our common stock at a price of $53.00 per share.
 
Item 6.   Exhibits
 
         
  31 .1   Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31 .2   Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32 .1   Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


48

Table of Contents

 
This excerpt taken from the BIIB 10-Q filed May 3, 2007.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		       
                Shares Purchased as
 		    Number of Shares
 		 
    Total Number of
 		    Average Price Paid
 		    Part of Publicly
 		    that may yet be
 		 
    Shares Purchased
 		    per Share
 		    Announced Program
 		    Purchased Under Our
 		 
Period
  (#)(a)     ($)     (#)(a)     Program (#)  
 
Three Months Ended March 31, 2007
    8,041 (b)   $ 44.99        —       20,000,000  
Total
    8,041     $ 44.99        —       20,000,000  
 
 
(a) On October 13, 2006 the Board of Directors authorized the repurchase of up to 20.0 million shares of our common stock. The repurchased stock will provide us with authorized shares for general corporate purposes, such as common stock to be issued under our employee equity and stock purchase plans. This repurchase program does not have an expiration date.
 
(b) All of these shares are shares that were used by certain employees to pay the exercise price of their stock options in lieu of paying cash or utilizing our cashless option exercise program.
 
Item 6.   Exhibits
 
         
  10 .1   Amendment dated April 4, 2006, to 2005 Omnibus Equity Plan.
  10 .2   Amendment dated February 12, 2007, to 2005 Omnibus Equity Plan.
  31 .1   Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31 .2   Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32 .1   Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


49

Table of Contents

This excerpt taken from the BIIB 10-K filed Mar 3, 2006.
Issuer Purchases of Equity Securities
 
                                 
                Total Number of
 		       
                Shares Purchased as
 		    Number of Shares
 		 
    Total Number of
 		          Part of Publicly
 		    that may yet be
 		 
    Shares Purchased
 		    Average Price Paid
 		    Announced Program
 		    Purchased under Our
 		 
Period
  (#)(a)     per Share ($)     (#)(a)     Program (#)  
 
October 2005
    130     $ 38.02       —       11,916,400  
November 2005
    —       —       —       11,916,400  
December 2005
    —       —       —       11,916,400  
                                 
Total
    130 (b)   $ 38.02       —       11,916,400  
 
 
(a)  In October 2004, our Board of Directors authorized the repurchase of up to 20 million shares of our common stock. This repurchase program will expire no later than October 4, 2006. We publicly announced the repurchase program in our press release dated October 27, 2004 which was furnished to (and not filed with) the SEC as Exhibit 99.1 of our Current Report of Form 8-K filed on October 27, 2004.
 
(b)  These shares were used by certain employees to pay the exercise price of their stock options in lieu of paying cash or utilizing our cashless option exercise program.


46

Table of Contents

 
Item 6.   Selected Consolidated Financial Data
 
The following financial data should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Form 10-K, beginning on page F-1.
 
BIOGEN IDEC INC. AND SUBSIDIARIES
 

EXCERPTS ON THIS PAGE:

10-Q
Apr 17, 2009
10-K
Feb 6, 2009
10-Q
Apr 23, 2008
10-K
Feb 14, 2008
10-Q
Oct 23, 2007
10-Q
May 3, 2007
10-K
Mar 3, 2006

RELATED TOPICS for BIIB:

"Issuer Purchases of Equity Securities" elsewhere:

Abbott Laboratories (ABT)
Pfizer (PFE)
JOHNSON & JOHNSON (JNJ)
BioMarin Pharmaceutical (BMRN)
Cephalon (CEPH)
Charles River Laboratories International (CRL)
Gilead Sciences (GILD)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki